MiNK Therapeutics, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-4.2M | $-4.2M | — | $785.5K |
| Mar 2023 | $-4.4M | $-4.4M | $13.5K | $921.1K |
| Mar 2024 | $-2.5M | $-2.5M | — | $592.0K |
| Mar 2025 | $-1.3M | $-1.3M | — | $591.1K |
| Mar 2026 | $-1.7M | $-1.7M | — | $630.4K |